| | Chracteristics | Total cohort | Survived, N (%) | Died, N (%) | Chi-sq. p | (95% CI) |
| | 5,417 | 5,260 (97) | 157 (3) | — | — | | Sex | — | — | — | 0.43 | — | | Male | 2,761 (51) | 2,676 (51) | 85 (54) | — | 1.20 (0.86, 1.62) | | Female | 2,651 (49) | 2,579 (49) | 72 (46) | — | — | | Age at diagnosis | — | — | — | <0.01 | — | | 0–7 | 2,126 (39) | 2,085 (40) | 41 (26) | — | — | | 8–15 | 3,291 (61) | 3,175 (60) | 116 (74) | — | 1.87 (1.31, 2.67) | | Year of diagnosis | — | — | — | <0.01 | — | | 1990–1999 | 2,294 (42) | 2,185 (42) | 109 (69) | — | 1.54 (1.06, 2.22) | | 2000–2009 | 3,123 (58) | 3,075 (58) | 48 (31) | — | — | | Socioeconomic status | — | — | — | 0.07 | — | | Most disadvantaged | 955 (18) | 920 (18) | 35 (22) | — | 1.81 (1.05, 3.11) | | Quintile 2–4 | 3,352 (62) | 3,252 (62) | 100 (64) | — | 1.42 (0.88, 2.30) | | Least disadvantaged | 1,102 (20) | 1,080 (21) | 22 (14) | — | — | | Area of residence | — | — | — | 0.15 | — | | Major cities | 3,665 (68) | 3,567 (68) | 98 (62) | — | — | | Regional or remote | 1,744 (32) | 1,685 (32) | 59 (38) | — | 1.13 (0.81, 1.58) |
|
|
